Skip to main content

This company has shut down. Ermium Therapeutics is no longer operating — its last tracked round was a Series A in 2022.

Explore the Startup Graveyard
ER

Ermium Therapeutics

Paris, France
Last funding
$6.3M
Series AJun 2022

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

Backed byKurma PartnersEurazeoIdinvest PartnersKainova TherapeuticsFountain Healthcare Partners

About Ermium Therapeutics

How much funding has Ermium Therapeutics raised?

Ermium Therapeutics has raised $6.3M in total funding. The most recent round was Series A. The last funding was announced in June 2022.

Who are Ermium Therapeutics's investors?

Ermium Therapeutics's investors include Kurma Partners, Eurazeo, Idinvest Partners, Kainova Therapeutics, Fountain Healthcare Partners.

Where is Ermium Therapeutics headquartered?

Ermium Therapeutics is headquartered in Paris, France.

What does Ermium Therapeutics do?

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

What stage is Ermium Therapeutics at?

Ermium Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ermium Therapeutics — Funding & Investors." VCBacked, June 30, 2022, https://www.vcbacked.co/company/ermium-therapeutics. Accessed November 22, 2026.
APA
VCBacked. (2022). Ermium Therapeutics — Funding & Investors. Retrieved November 22, 2026, from https://www.vcbacked.co/company/ermium-therapeutics
Wikipedia (cite web)
{{cite web |title=Ermium Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ermium-therapeutics |website=VCBacked |access-date=November 22, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Ermium Therapeutics? Request a listing update

Founder contacts
m***@ermium.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →